Issues
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Cancer Research
Table of Contents
Articles
Effects of Recombinant Human Tumor Necrosis Factor α, Recombinant Human γ-Interferon, and Prostaglandin E on Colony Formation of Human Hematopoietic Progenitor Cells Stimulated by Natural Human Pluripotent Colonystimulating Factor, Pluripoietin α, and Recombinant Erythropoietin in Serum-free Cultures1
Induction of Malignant Transformation of Cocultivated Hematopoietic Stem Cells by X-Irradiation of Murine Bone Marrow Stromal Cells in Vitro1
A Novel Monoclonal Antibody-defined Antigen Which Distinguishes Human Non-Small Cell from Small Cell Lung Carcinomas1
Identical Expression of Cell Surface Membrane Antigens on Two Parent and Eighteen Cloned Cell Lines Derived from Two Different Neuroblastoma Metastases of the Same Patient1
Two Novel Cell Surface Antigens on Small Cell Lung Carcinoma Defined by Mouse Monoclonal Antibodies NE-25 and PE-351
Multicenter Study of Immunoscintigraphy with Radiolabeled Monoclonal Antibodies in Patients with Melanoma1
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds